rs28904921
A SNP in the C11orf65 gene on chromosome 11. Its most notable genotype is G;T: ~8 fold increase in relative risk for breast cancer
- Gene
- C11orf65
- Location
- Chr 11108,329,202 (GRCh38)
- Highest magnitude
- 7.0Very important
- Tested on
- 23andMe, AncestryDNA
Genotypes
As shown in 23andMe and AncestryDNA files.
- G;TMost notableBad~8 fold increase in relative risk for breast cancer
- T;TGoodcommon in complete genomics
On SNPedia: (G;T), (T;T). Magnitude rates how notable a genotype is from 0 to 10, not how risky it is.
Related
Conditions, medicines and genes
Other C11orf65 SNPs
- rs17174393C;GBreast cancer associated mutationVery important
- rs564652222C;TBreast cancer associated mutationVery important
- rs587779852G;TBreast cancer associated mutationVery important
- rs587779861C;TBreast cancer associated mutationVery important
- rs587779866A;CBreast cancer associated mutationVery important
- rs587781302A;GBreast cancer associated mutationVery important
- rs587781584A;GBreast cancer associated mutationVery important
- rs587781722C;TBreast cancer associated mutationVery important
Notes
From SNPedia
Show notes, about 200 words
rs28904921, also known as c.7271T>G, p.Val2424Gly and V2424G, is a mutation in the ATM gene on chromosome 11. Although most high risk (causative) mutations for cancers prematurely truncate encoded proteins , the rs28904921(G) mutation is a missense variant that appears to lead to a quite high relative risk for breast cancer (relative risk increase of 8.0, CI: 2.8 to 22.5, p=0.0005). In contrast to most BRCA mutations, which are considered tumor suppressors and functionally recessive, this ATM mutation is considered a dominant negative, since loss of the wild-type allele in tumors with the ATM mutation is not consistently observed. Note that the confidence intervals are quite large, so although the relative risk is calculated as increasing eight-fold, the authors cited indicate that they can only state with 95% confidence that the "true" increase in relative risk lies somewhere between 2.8 and 22.5. Somewhat similarly, a 2016 publication study involving 42,000 breast cancer cases concluded that rs28904921(G) carriers had an odds ratio of 11 (CI:1.4-85; p=0.0012) and a 52% (CI: 28-80%) chance of developing the disease by age 70.
G;T
see discussion at rs28904921
Source and license
Adapted from rs28904921 on SNPedia, using a snapshot taken October 16, 2026. SNPedia content is shared under CC BY-NC-SA 3.0 US, and this page is shared under the same license.
SNPedia is a community-edited wiki. Its entries can be incomplete, out of date or wrong, and nothing here is a diagnosis or medical advice. Magnitude is a community rating of how interesting a genotype is, not a risk score.